MedTrace Logo

The Effect of Probiotic and Zinc Supplementation on the Common Cold

NCT04672850 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-04-12

No results posted yet for this study

Summary

The purpose with this study is to investigate the preventative effect of a supplement containing a combination of probiotic bacteria and fungi as well as zinc on the common cold. The hypothesis is that it will shorten the duration, alleviate the severity of symptoms or even decrease the number of infectons during the intervention period. This study is a randomzed placebo controlled human study were healthy adults will consume the supplement for three months.

Conditions

  • Common Cold

Interventions

DIETARY_SUPPLEMENT

Probiotic

The participants will consume 2 capsules daily for three months

DIETARY_SUPPLEMENT

Placebo

The participants will consume 2 capsules daily for three months

Sponsors & Collaborators

  • Coradil AB

    collaborator UNKNOWN

  • Lund University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-27
Primary Completion
2022-11-30
Completion
2022-11-30

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04672850 on ClinicalTrials.gov